OncoSenX Company
OncoSenX is a developer of transient gene therapies designed for solid tumors.
Estimated Revenue:
$10M to $50M
Industry:
Biotechnology, Health Care
Investor Type:
Seed
Last Funding Type:
Seed
Total Funding:
11700000
Headquarters:
Seattle, Washington, United States
Investors Number:
8
Last Funding Date:
2021
Founded Date:
2017
Employee Number:
1-10